Biora Therapeutics to Report Third Quarter 2022 Financial Results and Provide Corporate Update
November 07, 2022 16:15 ET
|
Biora Therapeutics, Inc.
SAN DIEGO, Nov. 07, 2022 (GLOBE NEWSWIRE) -- Biora Therapeutics, Inc. (Nasdaq: BIOR), the biotech company that is reimagining therapeutic delivery, today announced that it will report third quarter...
Biora Therapeutics Announces $9.75 Million Direct Offering
November 07, 2022 08:06 ET
|
Biora Therapeutics, Inc.
SAN DIEGO, Nov. 07, 2022 (GLOBE NEWSWIRE) -- Biora Therapeutics, Inc. (Nasdaq: BIOR), the biotech company that is reimagining therapeutic delivery, today announced that it has entered into a...
Biora Therapeutics Announces Sale of Cell-Free DNA Patent Rights
October 27, 2022 09:00 ET
|
Biora Therapeutics, Inc.
SAN DIEGO, Oct. 27, 2022 (GLOBE NEWSWIRE) -- Biora Therapeutics, Inc. (Nasdaq: BIOR), the biotech company that is reimagining therapeutic delivery, today announced it has completed a one-time asset...
Biora Therapeutics Shares Data from Device Performance Study in Ulcerative Colitis Patients
October 25, 2022 09:00 ET
|
Biora Therapeutics, Inc.
SAN DIEGO, Oct. 25, 2022 (GLOBE NEWSWIRE) -- Biora Therapeutics, Inc. (Nasdaq: BIOR), the biotech company that is reimagining therapeutic delivery, today presented detailed results from its PM-602...
Biora Therapeutics Shares Five Posters Presented at American College of Gastroenterology Annual Scientific Meeting 2022
October 24, 2022 09:00 ET
|
Biora Therapeutics, Inc.
SAN DIEGO, Oct. 24, 2022 (GLOBE NEWSWIRE) -- Biora Therapeutics, Inc. (Nasdaq: BIOR), the biotech company that is reimagining therapeutic delivery, today announced the five posters presented at the...
Biora Therapeutics Shares Preclinical Data on Oral Delivery of Biologics at the 2022 Parenteral Drug Association Universe of Pre-Filled Syringes and Injection Devices Conference
October 19, 2022 09:00 ET
|
Biora Therapeutics, Inc.
SAN DIEGO, Oct. 19, 2022 (GLOBE NEWSWIRE) -- Biora Therapeutics, Inc. (Nasdaq: BIOR), the biotech company that is reimagining therapeutics, today shared a poster presented at the Parenteral Drug...
Biora Therapeutics to Participate in 12th Annual Partnership Opportunities in Drug Delivery Conference
October 10, 2022 09:00 ET
|
Biora Therapeutics, Inc.
SAN DIEGO, Oct. 10, 2022 (GLOBE NEWSWIRE) -- Biora Therapeutics, Inc. (Nasdaq: BIOR), the biotech company that is reimagining therapeutics, announced today that the company will participate in the...
Biora Therapeutics Announces Issuance of Key Patent for Oral Delivery of GLP-1 Receptor Agonists
September 13, 2022 09:00 ET
|
Biora Therapeutics, Inc.
SAN DIEGO, Sept. 13, 2022 (GLOBE NEWSWIRE) -- Biora Therapeutics, Inc. (Nasdaq: BIOR), the biotech company that is reimagining therapeutics, announced today that the United States Patent and...
Biora Therapeutics Appoints Dr. Bruce Sands as Chair of its Clinical Advisory Board
September 07, 2022 09:00 ET
|
Biora Therapeutics, Inc.
SAN DIEGO, Sept. 07, 2022 (GLOBE NEWSWIRE) -- Biora Therapeutics, Inc. (Nasdaq: BIOR), the biotech company that is reimagining therapeutics, announced today the appointment of Dr. Bruce Sands as...
Biora Therapeutics to Participate in Upcoming H.C. Wainwright Investment Conference
September 06, 2022 06:30 ET
|
Biora Therapeutics, Inc.
SAN DIEGO, Sept. 06, 2022 (GLOBE NEWSWIRE) -- Biora Therapeutics, Inc. (Nasdaq: BIOR), the biotech company that is reimagining therapeutics, today announced that the company’s management team will...